Skip to content

Dagmara Mirowska-Guzel

Dagmara Mirowska-Guzel has been head of the Chair and Department of Experimental and Clinical Pharmacology at the Medical University of Warsaw since 2013.

She is specialized in neurology and clinical pharmacology. In 2002 and 2005-2006 she received several scientific grants, including those founded by the European Neurological Society, followed by those funded by the European Federation of Neurological Societies to conduct a project in the Max-Planck-Institute of Psychiatry in Munich. She took part in several clinical studies focused on immunomodulatory therapy in multiple sclerosis.

Currently she is President of the Committee on Therapeutics and Pharmaceuticals Science at the Polish Academy of Sciences, president elect of Polish Society of Clinical Pharmacology and Therapeutics, member of the presidential board of the Polish Pharmacological Society.

Her main area of interest is clinical pharmacology with special emphasis on drug safety, immunology and treatment of multiple sclerosis, neurotrophic factors in pathogenesis and course of neurological and cardiovascular diseases.

She is experienced in teaching, both at undergraduate and postgraduate level, she has delivered numerous invited lectures on clinical pharmacology and therapy of multiple sclerosis. She has been a supervisor of ten PhD theses, with two more underway.